Quetiapine fumarate
- Product NDC
- 67046-0637
- Requested package NDC
- 67046-0637-3
- 11-digit product format
- 670460637
- Labeler code
- 67046
- Product ID
- 67046-0637_52ba72f2-e3a4-89d2-e063-6294a90aa496
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- quetiapine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Coupler LLC
- Application
- ANDA201109
- Marketing category
- ANDA
- Marketing start
- 2026-05-26
- Substance
- QUETIAPINE FUMARATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201109-001 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | AB | 2012-03-27 | |
| A201109-002 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | AB | 2012-03-27 | |
| A201109-003 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | AB | 2012-03-27 | |
| A201109-004 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | AB | 2012-03-27 | |
| A201109-005 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | AB | 2012-03-27 | |
| A201109-006 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | AB | 2012-03-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201109-001 | AB |
| A201109-002 | AB |
| A201109-003 | AB |
| A201109-004 | AB |
| A201109-005 | AB |
| A201109-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A201109-001 | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET / ORAL | AB | 2012-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A201109-002 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET / ORAL | AB | 2012-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A201109-003 | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET / ORAL | AB | 2012-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A201109-004 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET / ORAL | AB | 2012-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A201109-005 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET / ORAL | AB | 2012-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A201109-006 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET / ORAL | AB | 2012-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A201109-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A201109-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A201109-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A201109-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A201109-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A201109-006 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quetiapine fumarate | QUETIAPINE FUMARATE | REMEDYREPACK INC. | c6c454c4-3eae-48ae-bf17-5dccdb659141 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | REMEDYREPACK INC. | d38f0f4e-dc0f-4c92-a212-c4da3db74801 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | REMEDYREPACK INC. | ea9b9ed1-4be0-4dc0-b1dd-239caff5253e | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | REMEDYREPACK INC. | 02b19885-2987-4c46-8d2a-5e59656f72e8 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | REMEDYREPACK INC. | 695415b1-083d-4540-9f41-bde4b201f834 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Bryant Ranch Prepack | 94a81681-381e-4b3b-89ac-e86dcbe7f890 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Bryant Ranch Prepack | fd9cce28-0052-4b0b-8a66-a1615e082d95 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Coupler LLC | 5643d339-50ea-405d-e063-6394a90a3b70 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Unit Dose Solutions, Inc. | 55f358e1-9458-b197-e063-6394a90a3f0e | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Unit Dose Solutions, Inc. | 55f574bc-ec55-93e2-e063-6394a90a1d47 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Unit Dose Solutions, Inc. | 559fdce5-ab3e-0d02-e063-6394a90a7fbd | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Unit Dose Solutions, Inc. | 55a5671b-7771-0adf-e063-6294a90acfa6 | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | St. Mary's Medical Park Pharmacy | 36248b77-277c-7d66-e063-6394a90ae1e8 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Coupler LLC | 544f6e91-e61f-c57a-e063-6294a90af9d1 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | St. Mary's Medical Park Pharmacy | 3624100f-6e3f-a2ad-e063-6294a90a0fc0 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Lupin Pharmaceuticals, Inc. | a951cd63-d329-47c9-965a-582fa73a07c6 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Coupler LLC | 533154bb-a596-c88b-e063-6294a90a8956 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE | Coupler LLC | 52ba669d-c846-03c2-e063-6394a90ac0f0 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 67046-0637-3 67046-0637 67046063703 |
| Quetiapine fumarate | QUETIAPINE | American Health Packaging | 9f927ae2-a0ae-4953-99ba-8de59ee5bfca | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
| Quetiapine fumarate | QUETIAPINE FUMARATE | Quallent Pharmaceuticals Health LLC | d51c5bf6-950d-493b-be55-de575c5ef2e7 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 201109 ANDA201109 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Quetiapine fumarate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| QUETIAPINE FUMARATE | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2S3PL1B6UJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 317174 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 52ba669d-c846-03c2-e063-6394a90ac0f0 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5ef42f82-f087-0d2c-105f-f791ca69210e | Product name | 8 | 20250729 |
| 21205abd-8c89-4943-9f85-908f3d4fc3bb | Product name | 5 | 20230501 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67046-0637-3 | Quetiapine fumarate | 30 in 1 BLISTER PACK | TABLET | 30 | 1 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 317174 | QUEtiapine fumarate 200 MG Oral Tablet | PSN | 52ba669d-c846-03c2-e063-6394a90ac0f0 | 1 |
| 317174 | quetiapine 200 MG Oral Tablet | SCD | 52ba669d-c846-03c2-e063-6394a90ac0f0 | 1 |
| 317174 | quetiapine (as quetiapine fumarate) 200 MG Oral Tablet | SY | 52ba669d-c846-03c2-e063-6394a90ac0f0 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 67046-0637-3 | 67046063703 | 30 TABLET in 1 BLISTER PACK (67046-0637-3) | 30 tablet | 2026-05-26 | No | No | Current |